De novo combination of lamivudine and adefovir versus entecavir monotherapy for the treatment of naïve HBeAg-negative chronic hepatitis B patients

PURPOSE: Either combination treatment or monotherapy using agents with a high genetic barrier are recommended for hepatitis B e antigen (HBeAg)-negative chronic hepatitis B (CHB). The aim of this study was to compare effect of naïve HBeAg-negative CHB patients with either de novo combination of lami...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Wang, Li-Chun, Chen, En-Qiang, Cao, Jing, Liu, Li, Zheng, Li, Li, Da-Jiang, Xu, Lu, Lei, Xue-Zhong, liu, Cong, Tang, Hong
Formato: Artigo
Idioma:Inglês
Publicado em: Springer-Verlag 2011
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3090546/
https://ncbi.nlm.nih.gov/pubmed/21484140
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12072-010-9243-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados